Intended for healthcare professionals

Analysis

Studying new antibiotics for multidrug resistant infections: are today’s patients paying for unproved future benefits?

BMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k587 (Published 22 February 2018) Cite this as: BMJ 2018;360:k587

Cited by...

Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections
- Abstract
- Fulltext
- PDF

See other articles in issue 8142

Article tools

Respond to this article
Print
Alerts & updates
Article alerts
Please note: your email address is provided to the journal, which may use this information for marketing purposes.

Log in or register:

Username *

Password *

Register for alerts

If you have registered for alerts, you should use your registered email address as your username
Citation tools
Download this article to citation manager

John H Powers professor of clinical medicine, Scott R Evans senior research scientist, Aaron S Kesselheim associate professor of medicine

Powers J H, Evans S R, Kesselheim A S. Studying new antibiotics for multidrug resistant infections: are today’s patients paying for unproved future benefits? BMJ 2018; 360 :k587 doi:10.1136/bmj.k587

BibTeX (win & mac)Download

EndNote (tagged)Download

EndNote 8 (xml)Download

RefWorks Tagged (win & mac)Download

RIS (win only)Download

MedlarsDownload

Help

If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

EndNote

ProCite

Reference Manager

RefWorks

Zotero
Request permissions

Warders Medical Centre: Salaried GP/Partner

Royal Cornwall Hospitals NHS Trust: Consultant - Eldercare / Geriatric Medicine - Parkinson's Interest

Royal Cornwall Hospitals NHS Trust: Consultant Dermatologist with an interest in Cutaneous Allergy

Royal Cornwall Hospitals NHS Trust: Consultant - Stroke Physician (from any previous background)

Glastonbury Health Centre: Salaried GP (Up to 6 sessions) - Glastonbury Health Centre